Kaplan Fox Files Class Action to Recover Losses for

NEW YORK, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has filed a proposed class action suit in the United...

Related Keywords

New York ,United States ,California ,New Jersey ,Oakland ,Chicago ,Illinois ,Larry King ,Laurenced King ,Los Angeles ,Jeffreyp Campisi ,Francoisj Lebel ,Norae Brennan ,Company Nasdaq ,Company Board Of Directors ,United States District Court ,Zenith ,Spectrum Pharmaceuticals Inc ,Oncologic Drugs Advisory Committee ,Securities Exchange ,Kaplan Fox Kilsheimer ,Southern District ,Spectrum Pharmaceuticals ,Chief Executive Officer ,Chief Medical Officer ,Chief Financial ,Securities Exchange Act ,Drugs Advisory Committee ,Class Period ,Kaplan Fox ,Kaplan Fox Amp Kilsheimer Llp ,Ppi Filing ,Pectrum Filing ,Complaint ,10b ,Ec ,For Investing ,Ppi ,Lass Action ,Securities Fraud ,Fda ,Ppi Investors ,